googleads

Global Organ Transplant Immunosuppressant Market 2017-2021

  • Published: Jul 2017
  • Pages: 128
  • SKU: IRTNTR13495
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

Organ transplant immunosuppressant market analysis

According to Technavio’s market research report, the global organ transplant immunosuppressant market will grow at a CAGR of close to 4% during the forecast period. One of the key drivers that will propel the growth prospects for the market during the estimated period is the complications associated with organ transplantation. The recipient body recognizes the transplanted organ or tissue as a foreign body and triggers a blood transfusion reaction. This leads to transplant rejection as a response to the recipient's immune system.

Transplant rejections can be of three types, which includes hyperacute rejection, acute rejection, or chronic rejection. This results in the emergence of immunosuppressive therapy, which is used to achieve a successful organ transplant. Cyclosporine is one of the best immunosuppressants and has established a benchmark of successful immunosuppression.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Introduction to organ transplantation

  • What is an organ transplantation?
  • How common is organ transplantation?
  • Increasing trend of organ transplantation
  • Need for immunosuppression during organ transplant
  • What is an immunosuppressant?
  • Role of an immunosuppressant during organ transplant

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Key clinical trials

PART 08: Market segmentation by drug class

  • Selective inhibitor of cytokine production and function
  • Immunosuppressive antimetabolites
  • Immunosuppressive antibodies
  • Immunosuppressive adrenocorticosteroids

PART 09: Market segmentation by therapeutic application

  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantation

PART 10: Geographical segmentation

  • Organ transplant immunosuppressant market in Americas
  • Organ transplant immunosuppressant market in EMEA
  • Organ transplant immunosuppressant market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges

  • Market drivers
  • Market challenges

PART 13: Market trends

  • Growing trend of medical tourism
  • New government initiatives on transplant research programs
  • Growing focus toward the use of biologics

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendor analysis

  • Astellas Pharma
  • Novartis
  • Pfizer
  • Sanofi
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations
Safe and Secure SSL Encrypted
Technavio
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

*For Enterprise license, go to checkout page

*Avail subscription at 50% off, with report purchase - limited to a week

  • 2500 USD


[5 reports/month/user]

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

  • 5000 USD

Quick BuyTechnavio
View Free Data Sample
VIEW FREE SAMPLE PDF

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights